nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—Gilles de la Tourette syndrome—Clonidine—glaucoma	0.389	1	CpDpCtD
Ziprasidone—ADRA2C—Brimonidine—glaucoma	0.0286	0.0651	CbGbCtD
Ziprasidone—ADRA2C—Apraclonidine—glaucoma	0.0286	0.0651	CbGbCtD
Ziprasidone—ADRA2B—Apraclonidine—glaucoma	0.0271	0.0618	CbGbCtD
Ziprasidone—ADRA2B—Brimonidine—glaucoma	0.0271	0.0618	CbGbCtD
Ziprasidone—ADRA2C—Dipivefrin—glaucoma	0.0228	0.0521	CbGbCtD
Ziprasidone—ADRA2B—Dipivefrin—glaucoma	0.0217	0.0494	CbGbCtD
Ziprasidone—CHRM3—Carbachol—glaucoma	0.0196	0.0447	CbGbCtD
Ziprasidone—ADRA2A—Apraclonidine—glaucoma	0.0189	0.043	CbGbCtD
Ziprasidone—ADRA2A—Brimonidine—glaucoma	0.0189	0.043	CbGbCtD
Ziprasidone—CHRM3—Pilocarpine—glaucoma	0.0182	0.0415	CbGbCtD
Ziprasidone—ADRA1A—Apraclonidine—glaucoma	0.0181	0.0412	CbGbCtD
Ziprasidone—CHRM1—Carbachol—glaucoma	0.0171	0.0389	CbGbCtD
Ziprasidone—CHRM1—Pilocarpine—glaucoma	0.0159	0.0361	CbGbCtD
Ziprasidone—CHRM2—Carbachol—glaucoma	0.0157	0.0358	CbGbCtD
Ziprasidone—ADRA2A—Dipivefrin—glaucoma	0.0151	0.0343	CbGbCtD
Ziprasidone—CHRM2—Pilocarpine—glaucoma	0.0146	0.0333	CbGbCtD
Ziprasidone—ADRA1A—Dipivefrin—glaucoma	0.0145	0.0329	CbGbCtD
Ziprasidone—ADRA2C—Clonidine—glaucoma	0.0119	0.027	CbGbCtD
Ziprasidone—ADRA2B—Clonidine—glaucoma	0.0113	0.0256	CbGbCtD
Ziprasidone—ADRA1B—Clonidine—glaucoma	0.00951	0.0217	CbGbCtD
Ziprasidone—ADRA2A—Clonidine—glaucoma	0.00783	0.0178	CbGbCtD
Ziprasidone—ADRA1A—Clonidine—glaucoma	0.00751	0.0171	CbGbCtD
Ziprasidone—CYP2D6—Carteolol—glaucoma	0.00704	0.016	CbGbCtD
Ziprasidone—CYP1A2—Betaxolol—glaucoma	0.00577	0.0131	CbGbCtD
Ziprasidone—CYP2D6—Betaxolol—glaucoma	0.00475	0.0108	CbGbCtD
Ziprasidone—CYP3A5—Clonidine—glaucoma	0.00425	0.00967	CbGbCtD
Ziprasidone—CYP2D6—Methazolamide—glaucoma	0.0036	0.00821	CbGbCtD
Ziprasidone—CYP3A4—Pilocarpine—glaucoma	0.00339	0.00772	CbGbCtD
Ziprasidone—CYP1A2—Clonidine—glaucoma	0.00316	0.0072	CbGbCtD
Ziprasidone—CYP2D6—Timolol—glaucoma	0.00306	0.00698	CbGbCtD
Ziprasidone—CYP3A4—Brinzolamide—glaucoma	0.00266	0.00606	CbGbCtD
Ziprasidone—CYP2D6—Clonidine—glaucoma	0.0026	0.00593	CbGbCtD
Ziprasidone—CYP3A4—Dorzolamide—glaucoma	0.00257	0.00585	CbGbCtD
Ziprasidone—CYP3A4—Methazolamide—glaucoma	0.00229	0.00522	CbGbCtD
Ziprasidone—CYP3A4—Acetazolamide—glaucoma	0.00183	0.00417	CbGbCtD
Ziprasidone—CYP3A4—Clonidine—glaucoma	0.00166	0.00377	CbGbCtD
Ziprasidone—DRD5—eyelid—glaucoma	0.00116	0.516	CbGeAlD
Ziprasidone—HTR7—endothelium—glaucoma	0.000125	0.0558	CbGeAlD
Ziprasidone—CHRM5—eye—glaucoma	0.000115	0.0515	CbGeAlD
Ziprasidone—H1F0—retina—glaucoma	9.86e-05	0.044	CbGeAlD
Ziprasidone—H1F0—connective tissue—glaucoma	9.59e-05	0.0428	CbGeAlD
Ziprasidone—HTR2A—endothelium—glaucoma	7.8e-05	0.0348	CbGeAlD
Ziprasidone—HTR1D—eye—glaucoma	7.71e-05	0.0344	CbGeAlD
Ziprasidone—HTR1D—connective tissue—glaucoma	7.43e-05	0.0331	CbGeAlD
Ziprasidone—HTR7—connective tissue—glaucoma	5.92e-05	0.0264	CbGeAlD
Ziprasidone—DRD2—eye—glaucoma	5.81e-05	0.0259	CbGeAlD
Ziprasidone—DRD2—retina—glaucoma	5.75e-05	0.0257	CbGeAlD
Ziprasidone—Decreased appetite—Brinzolamide—glaucoma	5.57e-05	0.000427	CcSEcCtD
Ziprasidone—Weight decreased—Timolol—glaucoma	5.56e-05	0.000427	CcSEcCtD
Ziprasidone—Constipation—Travoprost—glaucoma	5.55e-05	0.000426	CcSEcCtD
Ziprasidone—Hyperglycaemia—Timolol—glaucoma	5.55e-05	0.000426	CcSEcCtD
Ziprasidone—Agitation—Clonidine—glaucoma	5.53e-05	0.000425	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Brinzolamide—glaucoma	5.53e-05	0.000425	CcSEcCtD
Ziprasidone—Paraesthesia—Pilocarpine—glaucoma	5.53e-05	0.000424	CcSEcCtD
Ziprasidone—Asthenia—Bimatoprost—glaucoma	5.53e-05	0.000424	CcSEcCtD
Ziprasidone—Fatigue—Brinzolamide—glaucoma	5.52e-05	0.000424	CcSEcCtD
Ziprasidone—Angioedema—Clonidine—glaucoma	5.5e-05	0.000423	CcSEcCtD
Ziprasidone—Dyspnoea—Pilocarpine—glaucoma	5.49e-05	0.000421	CcSEcCtD
Ziprasidone—Somnolence—Pilocarpine—glaucoma	5.47e-05	0.00042	CcSEcCtD
Ziprasidone—Angiopathy—Betaxolol—glaucoma	5.46e-05	0.00042	CcSEcCtD
Ziprasidone—Immune system disorder—Betaxolol—glaucoma	5.44e-05	0.000418	CcSEcCtD
Ziprasidone—Diarrhoea—Apraclonidine—glaucoma	5.44e-05	0.000417	CcSEcCtD
Ziprasidone—Mediastinal disorder—Betaxolol—glaucoma	5.43e-05	0.000417	CcSEcCtD
Ziprasidone—Dyspepsia—Pilocarpine—glaucoma	5.42e-05	0.000416	CcSEcCtD
Ziprasidone—Chills—Betaxolol—glaucoma	5.4e-05	0.000415	CcSEcCtD
Ziprasidone—Syncope—Clonidine—glaucoma	5.4e-05	0.000415	CcSEcCtD
Ziprasidone—Arrhythmia—Betaxolol—glaucoma	5.38e-05	0.000413	CcSEcCtD
Ziprasidone—Feeling abnormal—Dorzolamide—glaucoma	5.37e-05	0.000412	CcSEcCtD
Ziprasidone—Decreased appetite—Pilocarpine—glaucoma	5.35e-05	0.000411	CcSEcCtD
Ziprasidone—Feeling abnormal—Travoprost—glaucoma	5.34e-05	0.00041	CcSEcCtD
Ziprasidone—Conjunctivitis—Timolol—glaucoma	5.33e-05	0.000409	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Dorzolamide—glaucoma	5.33e-05	0.000409	CcSEcCtD
Ziprasidone—Alopecia—Betaxolol—glaucoma	5.32e-05	0.000409	CcSEcCtD
Ziprasidone—Palpitations—Clonidine—glaucoma	5.32e-05	0.000409	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Pilocarpine—glaucoma	5.31e-05	0.000408	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Travoprost—glaucoma	5.3e-05	0.000407	CcSEcCtD
Ziprasidone—Loss of consciousness—Clonidine—glaucoma	5.29e-05	0.000406	CcSEcCtD
Ziprasidone—Feeling abnormal—Brinzolamide—glaucoma	5.28e-05	0.000405	CcSEcCtD
Ziprasidone—Mental disorder—Betaxolol—glaucoma	5.28e-05	0.000405	CcSEcCtD
Ziprasidone—Constipation—Pilocarpine—glaucoma	5.26e-05	0.000404	CcSEcCtD
Ziprasidone—Cough—Clonidine—glaucoma	5.26e-05	0.000404	CcSEcCtD
Ziprasidone—Sweating—Timolol—glaucoma	5.26e-05	0.000403	CcSEcCtD
Ziprasidone—Dizziness—Apraclonidine—glaucoma	5.25e-05	0.000403	CcSEcCtD
Ziprasidone—Erythema—Betaxolol—glaucoma	5.24e-05	0.000403	CcSEcCtD
Ziprasidone—Malnutrition—Betaxolol—glaucoma	5.24e-05	0.000403	CcSEcCtD
Ziprasidone—Urticaria—Dorzolamide—glaucoma	5.17e-05	0.000397	CcSEcCtD
Ziprasidone—Epistaxis—Timolol—glaucoma	5.17e-05	0.000397	CcSEcCtD
Ziprasidone—Body temperature increased—Dorzolamide—glaucoma	5.15e-05	0.000395	CcSEcCtD
Ziprasidone—Abdominal pain—Dorzolamide—glaucoma	5.15e-05	0.000395	CcSEcCtD
Ziprasidone—Chest pain—Clonidine—glaucoma	5.13e-05	0.000394	CcSEcCtD
Ziprasidone—Arthralgia—Clonidine—glaucoma	5.13e-05	0.000394	CcSEcCtD
Ziprasidone—Abdominal pain—Travoprost—glaucoma	5.13e-05	0.000394	CcSEcCtD
Ziprasidone—Anxiety—Clonidine—glaucoma	5.11e-05	0.000392	CcSEcCtD
Ziprasidone—Asthenia—Acetazolamide—glaucoma	5.1e-05	0.000391	CcSEcCtD
Ziprasidone—Dizziness—Bimatoprost—glaucoma	5.09e-05	0.000391	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	5.09e-05	0.000391	CcSEcCtD
Ziprasidone—Urticaria—Brinzolamide—glaucoma	5.09e-05	0.000391	CcSEcCtD
Ziprasidone—Feeling abnormal—Pilocarpine—glaucoma	5.07e-05	0.000389	CcSEcCtD
Ziprasidone—Vomiting—Apraclonidine—glaucoma	5.05e-05	0.000388	CcSEcCtD
Ziprasidone—Muscle spasms—Betaxolol—glaucoma	5.04e-05	0.000387	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Pilocarpine—glaucoma	5.03e-05	0.000386	CcSEcCtD
Ziprasidone—Hypersensitivity—Brimonidine—glaucoma	5.03e-05	0.000386	CcSEcCtD
Ziprasidone—Dry mouth—Clonidine—glaucoma	5.01e-05	0.000385	CcSEcCtD
Ziprasidone—Bradycardia—Timolol—glaucoma	5.01e-05	0.000385	CcSEcCtD
Ziprasidone—Dermatitis—Apraclonidine—glaucoma	5e-05	0.000384	CcSEcCtD
Ziprasidone—Headache—Apraclonidine—glaucoma	4.98e-05	0.000382	CcSEcCtD
Ziprasidone—Confusional state—Clonidine—glaucoma	4.96e-05	0.000381	CcSEcCtD
Ziprasidone—Vision blurred—Betaxolol—glaucoma	4.94e-05	0.000379	CcSEcCtD
Ziprasidone—Rhinitis—Timolol—glaucoma	4.93e-05	0.000379	CcSEcCtD
Ziprasidone—Tremor—Betaxolol—glaucoma	4.91e-05	0.000377	CcSEcCtD
Ziprasidone—Asthenia—Brimonidine—glaucoma	4.89e-05	0.000376	CcSEcCtD
Ziprasidone—Infection—Clonidine—glaucoma	4.88e-05	0.000375	CcSEcCtD
Ziprasidone—Abdominal pain—Pilocarpine—glaucoma	4.87e-05	0.000374	CcSEcCtD
Ziprasidone—Body temperature increased—Pilocarpine—glaucoma	4.87e-05	0.000374	CcSEcCtD
Ziprasidone—Diarrhoea—Acetazolamide—glaucoma	4.86e-05	0.000373	CcSEcCtD
Ziprasidone—Rash—Bimatoprost—glaucoma	4.86e-05	0.000373	CcSEcCtD
Ziprasidone—Dermatitis—Bimatoprost—glaucoma	4.85e-05	0.000373	CcSEcCtD
Ziprasidone—Oedema peripheral—Timolol—glaucoma	4.85e-05	0.000372	CcSEcCtD
Ziprasidone—Anaemia—Betaxolol—glaucoma	4.85e-05	0.000372	CcSEcCtD
Ziprasidone—Shock—Clonidine—glaucoma	4.84e-05	0.000371	CcSEcCtD
Ziprasidone—Connective tissue disorder—Timolol—glaucoma	4.84e-05	0.000371	CcSEcCtD
Ziprasidone—Headache—Bimatoprost—glaucoma	4.83e-05	0.000371	CcSEcCtD
Ziprasidone—Nervous system disorder—Clonidine—glaucoma	4.82e-05	0.00037	CcSEcCtD
Ziprasidone—Thrombocytopenia—Clonidine—glaucoma	4.81e-05	0.00037	CcSEcCtD
Ziprasidone—Hypersensitivity—Dorzolamide—glaucoma	4.8e-05	0.000368	CcSEcCtD
Ziprasidone—Tachycardia—Clonidine—glaucoma	4.8e-05	0.000368	CcSEcCtD
Ziprasidone—Hypersensitivity—Travoprost—glaucoma	4.78e-05	0.000367	CcSEcCtD
Ziprasidone—Skin disorder—Clonidine—glaucoma	4.77e-05	0.000367	CcSEcCtD
Ziprasidone—Hyperhidrosis—Clonidine—glaucoma	4.75e-05	0.000365	CcSEcCtD
Ziprasidone—Visual impairment—Timolol—glaucoma	4.74e-05	0.000364	CcSEcCtD
Ziprasidone—Nausea—Apraclonidine—glaucoma	4.72e-05	0.000362	CcSEcCtD
Ziprasidone—Hypersensitivity—Brinzolamide—glaucoma	4.72e-05	0.000362	CcSEcCtD
Ziprasidone—Vertigo—Betaxolol—glaucoma	4.71e-05	0.000362	CcSEcCtD
Ziprasidone—Syncope—Betaxolol—glaucoma	4.7e-05	0.000361	CcSEcCtD
Ziprasidone—Dizziness—Acetazolamide—glaucoma	4.7e-05	0.000361	CcSEcCtD
Ziprasidone—Anorexia—Clonidine—glaucoma	4.69e-05	0.00036	CcSEcCtD
Ziprasidone—Asthenia—Dorzolamide—glaucoma	4.67e-05	0.000359	CcSEcCtD
Ziprasidone—Asthenia—Travoprost—glaucoma	4.65e-05	0.000357	CcSEcCtD
Ziprasidone—Palpitations—Betaxolol—glaucoma	4.63e-05	0.000356	CcSEcCtD
Ziprasidone—Loss of consciousness—Betaxolol—glaucoma	4.61e-05	0.000354	CcSEcCtD
Ziprasidone—Eye disorder—Timolol—glaucoma	4.6e-05	0.000353	CcSEcCtD
Ziprasidone—Asthenia—Brinzolamide—glaucoma	4.59e-05	0.000353	CcSEcCtD
Ziprasidone—Hypotension—Clonidine—glaucoma	4.59e-05	0.000353	CcSEcCtD
Ziprasidone—Tinnitus—Timolol—glaucoma	4.59e-05	0.000352	CcSEcCtD
Ziprasidone—HRH1—eye—glaucoma	4.59e-05	0.0205	CbGeAlD
Ziprasidone—Cough—Betaxolol—glaucoma	4.58e-05	0.000351	CcSEcCtD
Ziprasidone—Nausea—Bimatoprost—glaucoma	4.58e-05	0.000351	CcSEcCtD
Ziprasidone—Cardiac disorder—Timolol—glaucoma	4.57e-05	0.000351	CcSEcCtD
Ziprasidone—Hypersensitivity—Pilocarpine—glaucoma	4.53e-05	0.000348	CcSEcCtD
Ziprasidone—Vomiting—Acetazolamide—glaucoma	4.52e-05	0.000347	CcSEcCtD
Ziprasidone—Dizziness—Brimonidine—glaucoma	4.51e-05	0.000346	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Clonidine—glaucoma	4.48e-05	0.000344	CcSEcCtD
Ziprasidone—Angiopathy—Timolol—glaucoma	4.46e-05	0.000343	CcSEcCtD
Ziprasidone—Chest pain—Betaxolol—glaucoma	4.46e-05	0.000343	CcSEcCtD
Ziprasidone—Arthralgia—Betaxolol—glaucoma	4.46e-05	0.000343	CcSEcCtD
Ziprasidone—Myalgia—Betaxolol—glaucoma	4.46e-05	0.000343	CcSEcCtD
Ziprasidone—Diarrhoea—Dorzolamide—glaucoma	4.46e-05	0.000342	CcSEcCtD
Ziprasidone—Headache—Acetazolamide—glaucoma	4.45e-05	0.000342	CcSEcCtD
Ziprasidone—Anxiety—Betaxolol—glaucoma	4.45e-05	0.000342	CcSEcCtD
Ziprasidone—Insomnia—Clonidine—glaucoma	4.45e-05	0.000341	CcSEcCtD
Ziprasidone—Immune system disorder—Timolol—glaucoma	4.44e-05	0.000341	CcSEcCtD
Ziprasidone—Diarrhoea—Travoprost—glaucoma	4.44e-05	0.000341	CcSEcCtD
Ziprasidone—Mediastinal disorder—Timolol—glaucoma	4.43e-05	0.000341	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	4.43e-05	0.00034	CcSEcCtD
Ziprasidone—HRH1—connective tissue—glaucoma	4.42e-05	0.0197	CbGeAlD
Ziprasidone—Asthenia—Pilocarpine—glaucoma	4.42e-05	0.000339	CcSEcCtD
Ziprasidone—Paraesthesia—Clonidine—glaucoma	4.41e-05	0.000339	CcSEcCtD
Ziprasidone—Arrhythmia—Timolol—glaucoma	4.4e-05	0.000338	CcSEcCtD
Ziprasidone—Dyspnoea—Clonidine—glaucoma	4.38e-05	0.000336	CcSEcCtD
Ziprasidone—Diarrhoea—Brinzolamide—glaucoma	4.38e-05	0.000336	CcSEcCtD
Ziprasidone—Somnolence—Clonidine—glaucoma	4.37e-05	0.000336	CcSEcCtD
Ziprasidone—Dry mouth—Betaxolol—glaucoma	4.37e-05	0.000335	CcSEcCtD
Ziprasidone—Alopecia—Timolol—glaucoma	4.35e-05	0.000334	CcSEcCtD
Ziprasidone—ADRA2A—connective tissue—glaucoma	4.34e-05	0.0194	CbGeAlD
Ziprasidone—Confusional state—Betaxolol—glaucoma	4.31e-05	0.000331	CcSEcCtD
Ziprasidone—Mental disorder—Timolol—glaucoma	4.31e-05	0.000331	CcSEcCtD
Ziprasidone—Dizziness—Dorzolamide—glaucoma	4.31e-05	0.000331	CcSEcCtD
Ziprasidone—Rash—Brimonidine—glaucoma	4.3e-05	0.00033	CcSEcCtD
Ziprasidone—Dermatitis—Brimonidine—glaucoma	4.3e-05	0.00033	CcSEcCtD
Ziprasidone—Dizziness—Travoprost—glaucoma	4.29e-05	0.000329	CcSEcCtD
Ziprasidone—Erythema—Timolol—glaucoma	4.28e-05	0.000329	CcSEcCtD
Ziprasidone—Malnutrition—Timolol—glaucoma	4.28e-05	0.000329	CcSEcCtD
Ziprasidone—Headache—Brimonidine—glaucoma	4.27e-05	0.000328	CcSEcCtD
Ziprasidone—Decreased appetite—Clonidine—glaucoma	4.27e-05	0.000328	CcSEcCtD
Ziprasidone—Infection—Betaxolol—glaucoma	4.25e-05	0.000326	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Clonidine—glaucoma	4.24e-05	0.000326	CcSEcCtD
Ziprasidone—Fatigue—Clonidine—glaucoma	4.24e-05	0.000325	CcSEcCtD
Ziprasidone—Dizziness—Brinzolamide—glaucoma	4.23e-05	0.000325	CcSEcCtD
Ziprasidone—Nausea—Acetazolamide—glaucoma	4.22e-05	0.000324	CcSEcCtD
Ziprasidone—Diarrhoea—Pilocarpine—glaucoma	4.21e-05	0.000323	CcSEcCtD
Ziprasidone—Shock—Betaxolol—glaucoma	4.21e-05	0.000323	CcSEcCtD
Ziprasidone—Constipation—Clonidine—glaucoma	4.2e-05	0.000323	CcSEcCtD
Ziprasidone—Nervous system disorder—Betaxolol—glaucoma	4.2e-05	0.000322	CcSEcCtD
Ziprasidone—Thrombocytopenia—Betaxolol—glaucoma	4.19e-05	0.000322	CcSEcCtD
Ziprasidone—Tachycardia—Betaxolol—glaucoma	4.18e-05	0.000321	CcSEcCtD
Ziprasidone—Skin disorder—Betaxolol—glaucoma	4.16e-05	0.000319	CcSEcCtD
Ziprasidone—Vomiting—Dorzolamide—glaucoma	4.14e-05	0.000318	CcSEcCtD
Ziprasidone—Hyperhidrosis—Betaxolol—glaucoma	4.14e-05	0.000318	CcSEcCtD
Ziprasidone—Rash—Dorzolamide—glaucoma	4.11e-05	0.000315	CcSEcCtD
Ziprasidone—Dermatitis—Dorzolamide—glaucoma	4.1e-05	0.000315	CcSEcCtD
Ziprasidone—Rash—Travoprost—glaucoma	4.09e-05	0.000314	CcSEcCtD
Ziprasidone—Dermatitis—Travoprost—glaucoma	4.09e-05	0.000314	CcSEcCtD
Ziprasidone—Headache—Dorzolamide—glaucoma	4.08e-05	0.000313	CcSEcCtD
Ziprasidone—Anorexia—Betaxolol—glaucoma	4.08e-05	0.000313	CcSEcCtD
Ziprasidone—Vomiting—Brinzolamide—glaucoma	4.07e-05	0.000313	CcSEcCtD
Ziprasidone—Dizziness—Pilocarpine—glaucoma	4.07e-05	0.000313	CcSEcCtD
Ziprasidone—Headache—Travoprost—glaucoma	4.06e-05	0.000312	CcSEcCtD
Ziprasidone—Nausea—Brimonidine—glaucoma	4.05e-05	0.000311	CcSEcCtD
Ziprasidone—Feeling abnormal—Clonidine—glaucoma	4.05e-05	0.000311	CcSEcCtD
Ziprasidone—Rash—Brinzolamide—glaucoma	4.04e-05	0.00031	CcSEcCtD
Ziprasidone—Vision blurred—Timolol—glaucoma	4.04e-05	0.00031	CcSEcCtD
Ziprasidone—Dermatitis—Brinzolamide—glaucoma	4.03e-05	0.00031	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Clonidine—glaucoma	4.02e-05	0.000309	CcSEcCtD
Ziprasidone—Headache—Brinzolamide—glaucoma	4.01e-05	0.000308	CcSEcCtD
Ziprasidone—Hypotension—Betaxolol—glaucoma	4e-05	0.000307	CcSEcCtD
Ziprasidone—Angioedema—Timolol—glaucoma	3.91e-05	0.000301	CcSEcCtD
Ziprasidone—Vomiting—Pilocarpine—glaucoma	3.91e-05	0.0003	CcSEcCtD
Ziprasidone—Urticaria—Clonidine—glaucoma	3.9e-05	0.0003	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Betaxolol—glaucoma	3.9e-05	0.000299	CcSEcCtD
Ziprasidone—Body temperature increased—Clonidine—glaucoma	3.89e-05	0.000298	CcSEcCtD
Ziprasidone—Abdominal pain—Clonidine—glaucoma	3.89e-05	0.000298	CcSEcCtD
Ziprasidone—Rash—Pilocarpine—glaucoma	3.88e-05	0.000298	CcSEcCtD
Ziprasidone—Dermatitis—Pilocarpine—glaucoma	3.88e-05	0.000298	CcSEcCtD
Ziprasidone—Insomnia—Betaxolol—glaucoma	3.87e-05	0.000297	CcSEcCtD
Ziprasidone—Nausea—Dorzolamide—glaucoma	3.87e-05	0.000297	CcSEcCtD
Ziprasidone—Headache—Pilocarpine—glaucoma	3.86e-05	0.000296	CcSEcCtD
Ziprasidone—Nausea—Travoprost—glaucoma	3.85e-05	0.000296	CcSEcCtD
Ziprasidone—Vertigo—Timolol—glaucoma	3.85e-05	0.000295	CcSEcCtD
Ziprasidone—Paraesthesia—Betaxolol—glaucoma	3.84e-05	0.000295	CcSEcCtD
Ziprasidone—Syncope—Timolol—glaucoma	3.84e-05	0.000295	CcSEcCtD
Ziprasidone—HTR2A—eye—glaucoma	3.83e-05	0.0171	CbGeAlD
Ziprasidone—Dyspnoea—Betaxolol—glaucoma	3.82e-05	0.000293	CcSEcCtD
Ziprasidone—Nausea—Brinzolamide—glaucoma	3.8e-05	0.000292	CcSEcCtD
Ziprasidone—HTR2A—retina—glaucoma	3.8e-05	0.0169	CbGeAlD
Ziprasidone—Palpitations—Timolol—glaucoma	3.79e-05	0.000291	CcSEcCtD
Ziprasidone—Dyspepsia—Betaxolol—glaucoma	3.77e-05	0.000289	CcSEcCtD
Ziprasidone—Loss of consciousness—Timolol—glaucoma	3.76e-05	0.000289	CcSEcCtD
Ziprasidone—Cough—Timolol—glaucoma	3.74e-05	0.000287	CcSEcCtD
Ziprasidone—Decreased appetite—Betaxolol—glaucoma	3.72e-05	0.000286	CcSEcCtD
Ziprasidone—Hypertension—Timolol—glaucoma	3.7e-05	0.000284	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Betaxolol—glaucoma	3.69e-05	0.000284	CcSEcCtD
Ziprasidone—HTR2A—connective tissue—glaucoma	3.69e-05	0.0165	CbGeAlD
Ziprasidone—Fatigue—Betaxolol—glaucoma	3.69e-05	0.000283	CcSEcCtD
Ziprasidone—Constipation—Betaxolol—glaucoma	3.66e-05	0.000281	CcSEcCtD
Ziprasidone—Nausea—Pilocarpine—glaucoma	3.66e-05	0.000281	CcSEcCtD
Ziprasidone—Chest pain—Timolol—glaucoma	3.65e-05	0.00028	CcSEcCtD
Ziprasidone—Myalgia—Timolol—glaucoma	3.65e-05	0.00028	CcSEcCtD
Ziprasidone—Arthralgia—Timolol—glaucoma	3.65e-05	0.00028	CcSEcCtD
Ziprasidone—Anxiety—Timolol—glaucoma	3.63e-05	0.000279	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	3.62e-05	0.000278	CcSEcCtD
Ziprasidone—Hypersensitivity—Clonidine—glaucoma	3.62e-05	0.000278	CcSEcCtD
Ziprasidone—Dry mouth—Timolol—glaucoma	3.57e-05	0.000274	CcSEcCtD
Ziprasidone—Asthenia—Clonidine—glaucoma	3.53e-05	0.000271	CcSEcCtD
Ziprasidone—Feeling abnormal—Betaxolol—glaucoma	3.53e-05	0.000271	CcSEcCtD
Ziprasidone—Confusional state—Timolol—glaucoma	3.53e-05	0.000271	CcSEcCtD
Ziprasidone—Infection—Timolol—glaucoma	3.47e-05	0.000267	CcSEcCtD
Ziprasidone—Shock—Timolol—glaucoma	3.44e-05	0.000264	CcSEcCtD
Ziprasidone—Nervous system disorder—Timolol—glaucoma	3.43e-05	0.000263	CcSEcCtD
Ziprasidone—Urticaria—Betaxolol—glaucoma	3.4e-05	0.000261	CcSEcCtD
Ziprasidone—Skin disorder—Timolol—glaucoma	3.4e-05	0.000261	CcSEcCtD
Ziprasidone—Body temperature increased—Betaxolol—glaucoma	3.38e-05	0.00026	CcSEcCtD
Ziprasidone—Hyperhidrosis—Timolol—glaucoma	3.38e-05	0.000259	CcSEcCtD
Ziprasidone—Diarrhoea—Clonidine—glaucoma	3.36e-05	0.000258	CcSEcCtD
Ziprasidone—Anorexia—Timolol—glaucoma	3.33e-05	0.000256	CcSEcCtD
Ziprasidone—Hypotension—Timolol—glaucoma	3.27e-05	0.000251	CcSEcCtD
Ziprasidone—Dizziness—Clonidine—glaucoma	3.25e-05	0.00025	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Timolol—glaucoma	3.19e-05	0.000245	CcSEcCtD
Ziprasidone—Insomnia—Timolol—glaucoma	3.16e-05	0.000243	CcSEcCtD
Ziprasidone—Hypersensitivity—Betaxolol—glaucoma	3.15e-05	0.000242	CcSEcCtD
Ziprasidone—Paraesthesia—Timolol—glaucoma	3.14e-05	0.000241	CcSEcCtD
Ziprasidone—Vomiting—Clonidine—glaucoma	3.13e-05	0.00024	CcSEcCtD
Ziprasidone—Dyspnoea—Timolol—glaucoma	3.12e-05	0.000239	CcSEcCtD
Ziprasidone—Somnolence—Timolol—glaucoma	3.11e-05	0.000239	CcSEcCtD
Ziprasidone—Rash—Clonidine—glaucoma	3.1e-05	0.000238	CcSEcCtD
Ziprasidone—Dermatitis—Clonidine—glaucoma	3.1e-05	0.000238	CcSEcCtD
Ziprasidone—Headache—Clonidine—glaucoma	3.08e-05	0.000236	CcSEcCtD
Ziprasidone—Dyspepsia—Timolol—glaucoma	3.08e-05	0.000236	CcSEcCtD
Ziprasidone—Asthenia—Betaxolol—glaucoma	3.07e-05	0.000236	CcSEcCtD
Ziprasidone—Decreased appetite—Timolol—glaucoma	3.04e-05	0.000233	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Timolol—glaucoma	3.02e-05	0.000232	CcSEcCtD
Ziprasidone—Fatigue—Timolol—glaucoma	3.01e-05	0.000231	CcSEcCtD
Ziprasidone—Diarrhoea—Betaxolol—glaucoma	2.93e-05	0.000225	CcSEcCtD
Ziprasidone—Nausea—Clonidine—glaucoma	2.92e-05	0.000224	CcSEcCtD
Ziprasidone—Feeling abnormal—Timolol—glaucoma	2.88e-05	0.000221	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Timolol—glaucoma	2.86e-05	0.000219	CcSEcCtD
Ziprasidone—Dizziness—Betaxolol—glaucoma	2.83e-05	0.000217	CcSEcCtD
Ziprasidone—Urticaria—Timolol—glaucoma	2.78e-05	0.000213	CcSEcCtD
Ziprasidone—Abdominal pain—Timolol—glaucoma	2.76e-05	0.000212	CcSEcCtD
Ziprasidone—Body temperature increased—Timolol—glaucoma	2.76e-05	0.000212	CcSEcCtD
Ziprasidone—Vomiting—Betaxolol—glaucoma	2.72e-05	0.000209	CcSEcCtD
Ziprasidone—Rash—Betaxolol—glaucoma	2.7e-05	0.000207	CcSEcCtD
Ziprasidone—Dermatitis—Betaxolol—glaucoma	2.7e-05	0.000207	CcSEcCtD
Ziprasidone—Headache—Betaxolol—glaucoma	2.68e-05	0.000206	CcSEcCtD
Ziprasidone—Hypersensitivity—Timolol—glaucoma	2.58e-05	0.000198	CcSEcCtD
Ziprasidone—Nausea—Betaxolol—glaucoma	2.54e-05	0.000195	CcSEcCtD
Ziprasidone—Asthenia—Timolol—glaucoma	2.51e-05	0.000193	CcSEcCtD
Ziprasidone—Diarrhoea—Timolol—glaucoma	2.39e-05	0.000184	CcSEcCtD
Ziprasidone—Dizziness—Timolol—glaucoma	2.31e-05	0.000178	CcSEcCtD
Ziprasidone—Vomiting—Timolol—glaucoma	2.22e-05	0.000171	CcSEcCtD
Ziprasidone—Rash—Timolol—glaucoma	2.2e-05	0.000169	CcSEcCtD
Ziprasidone—Dermatitis—Timolol—glaucoma	2.2e-05	0.000169	CcSEcCtD
Ziprasidone—Headache—Timolol—glaucoma	2.19e-05	0.000168	CcSEcCtD
Ziprasidone—Nausea—Timolol—glaucoma	2.08e-05	0.000159	CcSEcCtD
Ziprasidone—CHRM2—Signaling Pathways—CDKN2B—glaucoma	3.43e-06	8.72e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	3.43e-06	8.7e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—BAD—glaucoma	3.42e-06	8.7e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—FN1—glaucoma	3.42e-06	8.68e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EDN1—glaucoma	3.41e-06	8.66e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NGF—glaucoma	3.4e-06	8.64e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—C3—glaucoma	3.39e-06	8.62e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—BAD—glaucoma	3.38e-06	8.58e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—C3—glaucoma	3.38e-06	8.58e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—VEGFA—glaucoma	3.37e-06	8.57e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EDN1—glaucoma	3.36e-06	8.53e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EDN1—glaucoma	3.35e-06	8.51e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EDN1—glaucoma	3.34e-06	8.48e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EDN1—glaucoma	3.33e-06	8.45e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—MMP9—glaucoma	3.32e-06	8.44e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—GSTM1—glaucoma	3.31e-06	8.4e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EDN1—glaucoma	3.3e-06	8.37e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EDN1—glaucoma	3.29e-06	8.35e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—C3—glaucoma	3.28e-06	8.34e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—APOE—glaucoma	3.27e-06	8.31e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CAV1—glaucoma	3.24e-06	8.24e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—APOE—glaucoma	3.24e-06	8.22e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—C3—glaucoma	3.23e-06	8.21e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—CAV1—glaucoma	3.21e-06	8.15e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—NOS3—glaucoma	3.2e-06	8.12e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—NOS3—glaucoma	3.19e-06	8.11e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—MTHFR—glaucoma	3.19e-06	8.1e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	3.18e-06	8.08e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—NOS3—glaucoma	3.17e-06	8.06e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—APOE—glaucoma	3.16e-06	8.03e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—APOE—glaucoma	3.14e-06	7.98e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NGF—glaucoma	3.13e-06	7.96e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CAV1—glaucoma	3.13e-06	7.95e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GSTT1—glaucoma	3.13e-06	7.95e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CAV1—glaucoma	3.11e-06	7.91e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—TXN—glaucoma	3.11e-06	7.91e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—NOS3—glaucoma	3.11e-06	7.89e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—FN1—glaucoma	3.09e-06	7.84e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NGF—glaucoma	3.08e-06	7.83e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NGF—glaucoma	3.08e-06	7.82e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NGF—glaucoma	3.07e-06	7.79e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NGF—glaucoma	3.06e-06	7.77e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—NOS3—glaucoma	3.06e-06	7.77e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—APOE—glaucoma	3.06e-06	7.77e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EDN1—glaucoma	3.05e-06	7.76e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—BAD—glaucoma	3.05e-06	7.75e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CAV1—glaucoma	3.03e-06	7.69e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NGF—glaucoma	3.03e-06	7.69e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NGF—glaucoma	3.02e-06	7.67e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—NOS3—glaucoma	3.02e-06	7.66e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—APOE—glaucoma	3.01e-06	7.64e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Hemostasis—TP53—glaucoma	2.99e-06	7.59e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—VEGFA—glaucoma	2.99e-06	7.58e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CAV1—glaucoma	2.98e-06	7.57e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—C3—glaucoma	2.98e-06	7.57e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—FN1—glaucoma	2.98e-06	7.57e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—APOE—glaucoma	2.97e-06	7.54e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—FN1—glaucoma	2.96e-06	7.53e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—BAD—glaucoma	2.94e-06	7.48e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—CAV1—glaucoma	2.94e-06	7.47e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ABCA1—glaucoma	2.94e-06	7.47e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CYP1B1—glaucoma	2.94e-06	7.47e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—C3—glaucoma	2.93e-06	7.45e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—BAD—glaucoma	2.93e-06	7.44e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—C3—glaucoma	2.93e-06	7.43e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—MTHFR—glaucoma	2.92e-06	7.43e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—C3—glaucoma	2.92e-06	7.41e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—C3—glaucoma	2.91e-06	7.38e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—NOS3—glaucoma	2.89e-06	7.34e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—FN1—glaucoma	2.88e-06	7.32e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—C3—glaucoma	2.88e-06	7.31e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—C3—glaucoma	2.87e-06	7.29e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—BAD—glaucoma	2.85e-06	7.24e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—FN1—glaucoma	2.84e-06	7.21e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—NOS3—glaucoma	2.82e-06	7.16e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NGF—glaucoma	2.81e-06	7.13e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—BAD—glaucoma	2.8e-06	7.12e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—APOE—glaucoma	2.77e-06	7.05e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—CDKN1B—glaucoma	2.77e-06	7.04e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—CDKN1B—glaucoma	2.77e-06	7.03e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—NOS3—glaucoma	2.75e-06	6.99e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—CDKN1B—glaucoma	2.75e-06	6.98e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CAV1—glaucoma	2.75e-06	6.98e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—NOS3—glaucoma	2.74e-06	6.96e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—APOE—glaucoma	2.73e-06	6.93e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—APOE—glaucoma	2.72e-06	6.92e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—APOE—glaucoma	2.72e-06	6.91e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—NOS3—glaucoma	2.72e-06	6.9e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—APOE—glaucoma	2.72e-06	6.9e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—APOE—glaucoma	2.71e-06	6.87e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CAV1—glaucoma	2.7e-06	6.87e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CAV1—glaucoma	2.7e-06	6.86e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—CAV1—glaucoma	2.7e-06	6.85e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—CDKN1B—glaucoma	2.69e-06	6.84e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CAV1—glaucoma	2.69e-06	6.83e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CAV1—glaucoma	2.68e-06	6.81e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—APOE—glaucoma	2.68e-06	6.81e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—APOE—glaucoma	2.67e-06	6.79e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—C3—glaucoma	2.67e-06	6.78e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CAV1—glaucoma	2.66e-06	6.75e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—CDKN1B—glaucoma	2.65e-06	6.73e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CAV1—glaucoma	2.65e-06	6.73e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—FN1—glaucoma	2.62e-06	6.65e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—CDKN1B—glaucoma	2.61e-06	6.64e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—BAD—glaucoma	2.59e-06	6.57e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—PTGS2—glaucoma	2.58e-06	6.55e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—FN1—glaucoma	2.57e-06	6.54e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—FN1—glaucoma	2.57e-06	6.52e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—MMP9—glaucoma	2.57e-06	6.52e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—MMP9—glaucoma	2.56e-06	6.51e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—FN1—glaucoma	2.56e-06	6.5e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—FN1—glaucoma	2.55e-06	6.48e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—TP53—glaucoma	2.55e-06	6.47e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—MMP9—glaucoma	2.55e-06	6.47e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—BAD—glaucoma	2.54e-06	6.46e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—BAD—glaucoma	2.54e-06	6.45e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—BAD—glaucoma	2.53e-06	6.43e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—FN1—glaucoma	2.53e-06	6.42e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.52e-06	6.41e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—BAD—glaucoma	2.52e-06	6.41e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—FN1—glaucoma	2.52e-06	6.4e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—PTGS2—glaucoma	2.51e-06	6.36e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CDKN1B—glaucoma	2.5e-06	6.36e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—BAD—glaucoma	2.5e-06	6.34e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—MMP9—glaucoma	2.49e-06	6.33e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ABCA1—glaucoma	2.49e-06	6.33e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CYP1B1—glaucoma	2.49e-06	6.33e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—BAD—glaucoma	2.49e-06	6.33e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—APOE—glaucoma	2.48e-06	6.31e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CAV1—glaucoma	2.46e-06	6.25e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—MMP9—glaucoma	2.45e-06	6.23e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NOS3—glaucoma	2.45e-06	6.23e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—NOS3—glaucoma	2.43e-06	6.16e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—MMP9—glaucoma	2.42e-06	6.15e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GSTT1—glaucoma	2.41e-06	6.13e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CDKN1B—glaucoma	2.38e-06	6.06e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NOS3—glaucoma	2.37e-06	6.01e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NOS3—glaucoma	2.36e-06	5.98e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CDKN1B—glaucoma	2.35e-06	5.98e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—GSTM1—glaucoma	2.35e-06	5.97e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—FN1—glaucoma	2.34e-06	5.95e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MMP9—glaucoma	2.32e-06	5.89e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—BAD—glaucoma	2.31e-06	5.88e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—VEGFA—glaucoma	2.3e-06	5.85e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—VEGFA—glaucoma	2.3e-06	5.85e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NOS3—glaucoma	2.29e-06	5.82e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—VEGFA—glaucoma	2.29e-06	5.81e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—TP53—glaucoma	2.26e-06	5.73e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NOS3—glaucoma	2.25e-06	5.73e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—VEGFA—glaucoma	2.24e-06	5.69e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—NOS3—glaucoma	2.23e-06	5.65e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PTGS2—glaucoma	2.22e-06	5.63e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MMP9—glaucoma	2.21e-06	5.61e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—VEGFA—glaucoma	2.2e-06	5.6e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MMP9—glaucoma	2.18e-06	5.54e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—VEGFA—glaucoma	2.17e-06	5.52e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	2.12e-06	5.4e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—VEGFA—glaucoma	2.08e-06	5.29e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—MTHFR—glaucoma	2.08e-06	5.28e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NOS3—glaucoma	2.08e-06	5.28e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CDKN1B—glaucoma	2.05e-06	5.21e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NOS3—glaucoma	2.05e-06	5.19e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NOS3—glaucoma	2.04e-06	5.18e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CDKN1B—glaucoma	2.04e-06	5.18e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—NOS3—glaucoma	2.04e-06	5.18e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PTGS2—glaucoma	2.04e-06	5.17e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NOS3—glaucoma	2.03e-06	5.17e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NOS3—glaucoma	2.03e-06	5.15e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NOS3—glaucoma	2.01e-06	5.1e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NOS3—glaucoma	2e-06	5.09e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GSTM1—glaucoma	1.99e-06	5.06e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	1.98e-06	5.04e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—VEGFA—glaucoma	1.98e-06	5.04e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MMP9—glaucoma	1.97e-06	5e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—VEGFA—glaucoma	1.96e-06	4.97e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	1.95e-06	4.96e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—APOE—glaucoma	1.94e-06	4.92e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ABCA1—glaucoma	1.92e-06	4.89e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CYP1B1—glaucoma	1.92e-06	4.89e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—CAV1—glaucoma	1.92e-06	4.87e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MMP9—glaucoma	1.9e-06	4.82e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MMP9—glaucoma	1.89e-06	4.8e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—glaucoma	1.87e-06	4.74e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NOS3—glaucoma	1.86e-06	4.73e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MMP9—glaucoma	1.84e-06	4.67e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MMP9—glaucoma	1.81e-06	4.59e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CDKN1B—glaucoma	1.8e-06	4.57e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CDKN1B—glaucoma	1.77e-06	4.5e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CDKN1B—glaucoma	1.77e-06	4.49e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—VEGFA—glaucoma	1.77e-06	4.49e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CDKN1B—glaucoma	1.76e-06	4.48e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—MTHFR—glaucoma	1.76e-06	4.47e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CDKN1B—glaucoma	1.76e-06	4.46e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TP53—glaucoma	1.74e-06	4.42e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CDKN1B—glaucoma	1.74e-06	4.42e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TP53—glaucoma	1.74e-06	4.42e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	1.73e-06	4.41e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TP53—glaucoma	1.73e-06	4.39e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—VEGFA—glaucoma	1.71e-06	4.33e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—VEGFA—glaucoma	1.7e-06	4.31e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TP53—glaucoma	1.69e-06	4.3e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MMP9—glaucoma	1.67e-06	4.24e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TP53—glaucoma	1.66e-06	4.23e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—VEGFA—glaucoma	1.65e-06	4.19e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TP53—glaucoma	1.64e-06	4.17e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MMP9—glaucoma	1.64e-06	4.17e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOE—glaucoma	1.64e-06	4.16e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MMP9—glaucoma	1.64e-06	4.16e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MMP9—glaucoma	1.63e-06	4.15e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MMP9—glaucoma	1.63e-06	4.13e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CAV1—glaucoma	1.62e-06	4.13e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—VEGFA—glaucoma	1.62e-06	4.13e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	1.61e-06	4.09e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MMP9—glaucoma	1.61e-06	4.09e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MMP9—glaucoma	1.61e-06	4.08e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TP53—glaucoma	1.57e-06	3.99e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GSTM1—glaucoma	1.54e-06	3.91e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TP53—glaucoma	1.5e-06	3.81e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—VEGFA—glaucoma	1.5e-06	3.8e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MMP9—glaucoma	1.49e-06	3.79e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TP53—glaucoma	1.48e-06	3.76e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—VEGFA—glaucoma	1.47e-06	3.74e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—VEGFA—glaucoma	1.47e-06	3.73e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—VEGFA—glaucoma	1.47e-06	3.72e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—VEGFA—glaucoma	1.46e-06	3.71e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—NOS3—glaucoma	1.45e-06	3.68e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—VEGFA—glaucoma	1.45e-06	3.67e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—VEGFA—glaucoma	1.44e-06	3.66e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MTHFR—glaucoma	1.36e-06	3.45e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—VEGFA—glaucoma	1.34e-06	3.4e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TP53—glaucoma	1.33e-06	3.39e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—glaucoma	1.33e-06	3.37e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TP53—glaucoma	1.29e-06	3.27e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TP53—glaucoma	1.28e-06	3.26e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOE—glaucoma	1.27e-06	3.21e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CAV1—glaucoma	1.25e-06	3.18e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TP53—glaucoma	1.25e-06	3.17e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—NOS3—glaucoma	1.23e-06	3.12e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TP53—glaucoma	1.23e-06	3.12e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TP53—glaucoma	1.13e-06	2.87e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—glaucoma	1.12e-06	2.85e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TP53—glaucoma	1.11e-06	2.83e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TP53—glaucoma	1.11e-06	2.82e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TP53—glaucoma	1.11e-06	2.81e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TP53—glaucoma	1.1e-06	2.8e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TP53—glaucoma	1.09e-06	2.78e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TP53—glaucoma	1.09e-06	2.77e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TP53—glaucoma	1.01e-06	2.57e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NOS3—glaucoma	9.48e-07	2.41e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—glaucoma	8.67e-07	2.2e-05	CbGpPWpGaD
